| Financial Year |
March 31 2023 |
| Monetary Funds |
6,080,653,751.42 |
| Held-for-trading Financial Assets |
584,228,137.71 |
| Notes Receivable |
2,179,789.73 |
| Accounts Receivable |
470,873,693.27 |
| Advances to Suppliers |
58,323,218.52 |
| Other Receivables |
24,455,842.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,011,540,874.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
206,111,852.70 |
| Total Current Assets |
10,438,367,161.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,621,560.82 |
| Investment Properties |
-- |
| Fixed Assetes |
3,314,554,043.10 |
| Under-construction Projects |
889,910,250.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
692,125,481.41 |
| R&D expenses |
-- |
| Goodwill |
806,500,011.98 |
| Long-Term Deferred and Prepaid Expenses |
36,919,604.67 |
| Deferred Income Tax Assets |
152,317,996.30 |
| Other Non-Current Assets |
73,175,593.68 |
| Sub-Total of Non-Current Assets |
5,979,953,254.29 |
| Total Assets |
16,418,320,415.37 |
| Short-Term Loans |
386,665,801.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
269,184,383.62 |
| Accounts Payable |
1,169,738,434.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
135,531,746.47 |
| Taxes Payable |
152,775,496.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
436,803,322.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,584,633.39 |
| Other Current Liabilities |
388,264,791.27 |
| Sub-Total of Current Liabilities |
3,638,803,687.06 |
| Long-term Loans |
52,068,586.10 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
93,622.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
222,526,421.05 |
| Other Non-Current Liabilities |
13,601,000.00 |
| Sub-Total of Non-Current Liabilities |
462,032,944.64 |
| Total Liabilities |
4,100,836,631.70 |
| Paid-In Capital(Or Share Stock) |
293,294,232.00 |
| Capital Surplus |
8,024,122,694.83 |
| Surplus Reserve |
147,905,530.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,624,429,601.38 |
| Minority Stockholder's Interest |
228,996,134.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,088,487,649.22 |
| Owner's Equity（Stockholder's Equity） |
12,317,483,783.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,418,320,415.37 |
